 | • レポートコード：20QY06-03433 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ブルセラ症ワクチンのグローバル市場について種類別（S19ワクチン、RB51ワクチン株、その他）、用途別（牛、羊、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ブルセラ症ワクチン市場の概要 ・世界の主要地域別ブルセラ症ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のブルセラ症ワクチン市場規模2015-2026：種類別（S19ワクチン、RB51ワクチン株、その他） ・世界のブルセラ症ワクチン市場規模2015-2026：用途別（牛、羊、その他） ・ブルセラ症ワクチンの北米市場規模2015-2020 ・ブルセラ症ワクチンのヨーロッパ市場規模2015-2020 ・ブルセラ症ワクチンの中国市場規模2015-2020 ・ブルセラ症ワクチンの日本市場規模2015-2020 ・ブルセラ症ワクチンの東南アジア市場規模2015-2020 ・ブルセラ症ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jinyu、、Colorado Serum、、Boehringer Ingelheim、、Biogenesis-Bago、、Vetal Company、、CZ Veterinaria、、SYVA Laboratorios、、Indian Immunologicals、、Qilu、、Tecnovax、、Hester Biosciences、、Zoetis、、Onderstepoort Biological、、Instituto Rosenbusch、、Ceva Sante Animale、、Calier & Biologicos Laverlam、、Biovet、） ・ブルセラ症ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ブルセラ症ワクチンの市場動向・機会・課題 ・調査の結論 |
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
The classification of Brucellosis Vaccines includes S19 Vaccine, RB51 Vaccine Strain and Other. And the proportion of S19 Vaccine in 2016 is about 86%, and the proportion is stable from 2012 to 2016.
Brucellosis Vaccines is widely used in Cattle, Sheep and Other Animal. The most proportion of Brucellosis Vaccines is for Cattle with market share about 60 in 2016.
Market Analysis and Insights: Global Brucellosis Vaccines Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Brucellosis Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Brucellosis Vaccines industry.
Based on our recent survey, we have several different scenarios about the Brucellosis Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 10 million in 2019. The market size of Brucellosis Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Brucellosis Vaccines Scope and Market Size
The global Brucellosis Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brucellosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Brucellosis Vaccines market is segmented into
S19 Vaccine
RB51 Vaccine Strain
Other
Segment by Application, the Brucellosis Vaccines market is segmented into
Cattle
Sheep
Other
The Brucellosis Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Brucellosis Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Brucellosis Vaccines Market Share Analysis
Brucellosis Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Brucellosis Vaccines business, the date to enter into the Brucellosis Vaccines market, Brucellosis Vaccines product introduction, recent developments, etc.
The major vendors covered:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
レポート目次1 Brucellosis Vaccines Market Overview
1.1 Brucellosis Vaccines Product Scope
1.2 Brucellosis Vaccines Segment by Type
1.2.1 Global Brucellosis Vaccines Sales by Type (2020-2026)
1.2.2 S19 Vaccine
1.2.3 RB51 Vaccine Strain
1.2.4 Other
1.3 Brucellosis Vaccines Segment by Application
1.3.1 Global Brucellosis Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Other
1.4 Brucellosis Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Brucellosis Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Brucellosis Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Brucellosis Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Brucellosis Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Brucellosis Vaccines Industry
1.5.1.1 Brucellosis Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Brucellosis Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Brucellosis Vaccines Players to Combat Covid-19 Impact
2 Brucellosis Vaccines Estimate and Forecast by Region
2.1 Global Brucellosis Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Brucellosis Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Brucellosis Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Brucellosis Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Brucellosis Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Brucellosis Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Brucellosis Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Brucellosis Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Brucellosis Vaccines Estimates and Projections (2015-2026)
2.4.3 China Brucellosis Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Brucellosis Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Brucellosis Vaccines Estimates and Projections (2015-2026)
2.4.6 India Brucellosis Vaccines Estimates and Projections (2015-2026)
3 Global Brucellosis Vaccines Competition Landscape by Players
3.1 Global Top Brucellosis Vaccines Players by Sales (2015-2020)
3.2 Global Top Brucellosis Vaccines Players by Revenue (2015-2020)
3.3 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2019)
3.4 Global Brucellosis Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Brucellosis Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Brucellosis Vaccines Players (Opinion Leaders)
4 Global Brucellosis Vaccines Market Size by Type
4.1 Global Brucellosis Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Brucellosis Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Brucellosis Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Brucellosis Vaccines Price by Type (2014-2020)
4.2 Global Brucellosis Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Brucellosis Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Brucellosis Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Brucellosis Vaccines Price Forecast by Type (2021-2026)
5 Global Brucellosis Vaccines Market Size by Application
5.1 Global Brucellosis Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Brucellosis Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Brucellosis Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Brucellosis Vaccines Price by Application (2015-2020)
5.2 Global Brucellosis Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Brucellosis Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Brucellosis Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Brucellosis Vaccines Price Forecast by Application (2021-2026)
3 North America Brucellosis Vaccines Market Facts & Figures
3.2 North America Brucellosis Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Brucellosis Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Brucellosis Vaccines Sales Market Share by Application (2015-2020)
4 Europe Brucellosis Vaccines Market Facts & Figures
4.2 Europe Brucellosis Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Brucellosis Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Brucellosis Vaccines Sales Market Share by Application (2015-2020)
5 China Brucellosis Vaccines Market Facts & Figures
5.2 China Brucellosis Vaccines Sales Market Share by Company (2015-2020)
5.3 China Brucellosis Vaccines Sales Market Share by Type (2015-2020)
5.4 China Brucellosis Vaccines Sales Market Share by Application (2015-2020)
6 Japan Brucellosis Vaccines Market Facts & Figures
6.2 Japan Brucellosis Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Brucellosis Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Brucellosis Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Brucellosis Vaccines Market Facts & Figures
7.2 Southeast Asia Brucellosis Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Brucellosis Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Brucellosis Vaccines Sales Market Share by Application (2015-2020)
8 India Brucellosis Vaccines Market Facts & Figures
8.2 India Brucellosis Vaccines Sales Market Share by Company (2015-2020)
8.3 India Brucellosis Vaccines Sales Market Share by Type (2015-2020)
8.4 India Brucellosis Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Brucellosis Vaccines Business
12.1 Jinyu
12.1.1 Jinyu Brucellosis Vaccines Corporation Information
12.1.2 Jinyu Brucellosis Vaccines Business Overview and Total Revenue
12.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Jinyu Brucellosis Vaccines Products Offered
12.1.5 Jinyu Recent Development
12.2 Colorado Serum
12.2.1 Colorado Serum Brucellosis Vaccines Corporation Information
12.2.2 Colorado Serum Brucellosis Vaccines Business Overview and Total Revenue
12.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Colorado Serum Brucellosis Vaccines Products Offered
12.2.5 Colorado Serum Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Brucellosis Vaccines Corporation Information
12.3.2 Boehringer Ingelheim Brucellosis Vaccines Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Brucellosis Vaccines Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Biogenesis-Bago
12.4.1 Biogenesis-Bago Brucellosis Vaccines Corporation Information
12.4.2 Biogenesis-Bago Brucellosis Vaccines Business Overview and Total Revenue
12.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biogenesis-Bago Brucellosis Vaccines Products Offered
12.4.5 Biogenesis-Bago Recent Development
12.5 Vetal Company
12.5.1 Vetal Company Brucellosis Vaccines Corporation Information
12.5.2 Vetal Company Brucellosis Vaccines Business Overview and Total Revenue
12.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Vetal Company Brucellosis Vaccines Products Offered
12.5.5 Vetal Company Recent Development
12.6 CZ Veterinaria
12.6.1 CZ Veterinaria Brucellosis Vaccines Corporation Information
12.6.2 CZ Veterinaria Brucellosis Vaccines Business Overview and Total Revenue
12.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 CZ Veterinaria Brucellosis Vaccines Products Offered
12.6.5 CZ Veterinaria Recent Development
12.7 SYVA Laboratorios
12.7.1 SYVA Laboratorios Brucellosis Vaccines Corporation Information
12.7.2 SYVA Laboratorios Brucellosis Vaccines Business Overview and Total Revenue
12.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 SYVA Laboratorios Brucellosis Vaccines Products Offered
12.7.5 SYVA Laboratorios Recent Development
12.8 Indian Immunologicals
12.8.1 Indian Immunologicals Brucellosis Vaccines Corporation Information
12.8.2 Indian Immunologicals Brucellosis Vaccines Business Overview and Total Revenue
12.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Indian Immunologicals Brucellosis Vaccines Products Offered
12.8.5 Indian Immunologicals Recent Development
12.9 Qilu
12.9.1 Qilu Brucellosis Vaccines Corporation Information
12.9.2 Qilu Brucellosis Vaccines Business Overview and Total Revenue
12.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Qilu Brucellosis Vaccines Products Offered
12.9.5 Qilu Recent Development
12.10 Tecnovax
12.10.1 Tecnovax Brucellosis Vaccines Corporation Information
12.10.2 Tecnovax Brucellosis Vaccines Business Overview and Total Revenue
12.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Tecnovax Brucellosis Vaccines Products Offered
12.10.5 Tecnovax Recent Development
12.11 Hester Biosciences
12.11.1 Hester Biosciences Brucellosis Vaccines Corporation Information
12.11.2 Hester Biosciences Brucellosis Vaccines Business Overview and Total Revenue
12.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hester Biosciences Brucellosis Vaccines Products Offered
12.11.5 Hester Biosciences Recent Development
12.12 Zoetis
12.12.1 Zoetis Brucellosis Vaccines Corporation Information
12.12.2 Zoetis Brucellosis Vaccines Business Overview and Total Revenue
12.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Zoetis Brucellosis Vaccines Products Offered
12.12.5 Zoetis Recent Development
12.13 Onderstepoort Biological
12.13.1 Onderstepoort Biological Brucellosis Vaccines Corporation Information
12.13.2 Onderstepoort Biological Brucellosis Vaccines Business Overview and Total Revenue
12.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Onderstepoort Biological Brucellosis Vaccines Products Offered
12.13.5 Onderstepoort Biological Recent Development
12.14 Instituto Rosenbusch
12.14.1 Instituto Rosenbusch Brucellosis Vaccines Corporation Information
12.14.2 Instituto Rosenbusch Brucellosis Vaccines Business Overview and Total Revenue
12.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Instituto Rosenbusch Brucellosis Vaccines Products Offered
12.14.5 Instituto Rosenbusch Recent Development
12.15 Ceva Sante Animale
12.15.1 Ceva Sante Animale Brucellosis Vaccines Corporation Information
12.15.2 Ceva Sante Animale Brucellosis Vaccines Business Overview and Total Revenue
12.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Ceva Sante Animale Brucellosis Vaccines Products Offered
12.15.5 Ceva Sante Animale Recent Development
12.16 Calier & Biologicos Laverlam
12.16.1 Calier & Biologicos Laverlam Brucellosis Vaccines Corporation Information
12.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Business Overview and Total Revenue
12.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Products Offered
12.16.5 Calier & Biologicos Laverlam Recent Development
12.17 Biovet
12.17.1 Biovet Brucellosis Vaccines Corporation Information
12.17.2 Biovet Brucellosis Vaccines Business Overview and Total Revenue
12.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Biovet Brucellosis Vaccines Products Offered
12.17.5 Biovet Recent Development
13 Brucellosis Vaccines Manufacturing Cost Analysis
13.1 Brucellosis Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Brucellosis Vaccines
13.4 Brucellosis Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Brucellosis Vaccines Distributors List
14.3 Brucellosis Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of TablesTable 1. Global Brucellosis Vaccines Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Brucellosis Vaccines Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Brucellosis Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Brucellosis Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Brucellosis Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Brucellosis Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Brucellosis Vaccines Sales (M Doses) by Region (2015-2020)
Table 10. Global Brucellosis Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Brucellosis Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Brucellosis Vaccines Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Brucellosis Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Brucellosis Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Brucellosis Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Brucellosis Vaccines (M Doses) of Key Companies (2015-2020)
Table 18. Global Brucellosis Vaccines Sales Share by Company (2015-2020)
Table 19. Global Brucellosis Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Brucellosis Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2019)
Table 22. Global Brucellosis Vaccines Average Price (USD/K Doses) of Key Company (2015-2020)
Table 23. Manufacturers Brucellosis Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Brucellosis Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Brucellosis Vaccines Players
Table 27. Global Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 28. Global Brucellosis Vaccines Sales Share by Type (2015-2020)
Table 29. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Brucellosis Vaccines Price (M Doses) by Type (2015-2020)
Table 31. Global Brucellosis Vaccines Sales Share by Type (2021-2026)
Table 32. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Brucellosis Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Brucellosis Vaccines Price (M Doses) by Type (2021-2026)
Table 35. Global Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 36. Global Brucellosis Vaccines Sales Share by Application (2015-2020)
Table 37. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Brucellosis Vaccines Price (M Doses) by Application (2015-2020)
Table 39. Global Brucellosis Vaccines Sales (M Doses) by Application (2021-2026)
Table 40. Global Brucellosis Vaccines Sales Share by Application (2021-2026)
Table 41. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Brucellosis Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Brucellosis Vaccines Price (M Doses) by Application (2021-2026)
Table 44. United States Brucellosis Vaccines Sales (M Doses) by Company (2015-2020)
Table 45. United States Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 47. United States Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 49. United States Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Brucellosis Vaccines Sales (M Doses) by Company (2015-2020)
Table 51. Europe Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 53. Europe Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 55. Europe Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Brucellosis Vaccines Sales (M Doses) by Company (2015-2020)
Table 57. China Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 59. China Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 61. China Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Brucellosis Vaccines Sales (M Doses) by Company (2015-2020)
Table 63. Japan Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 65. Japan Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 67. Japan Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Brucellosis Vaccines Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Brucellosis Vaccines Sales (M Doses) by Company (2015-2020)
Table 75. India Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 77. India Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 79. India Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 80. Jinyu Corporation Information
Table 81. Jinyu Description and Business Overview
Table 82. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 83. Jinyu Brucellosis Vaccines Product
Table 84. Jinyu Recent Development
Table 85. Colorado Serum Corporation Information
Table 86. Colorado Serum Description and Business Overview
Table 87. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 88. Colorado Serum Brucellosis Vaccines Product
Table 89. Colorado Serum Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Brucellosis Vaccines Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Biogenesis-Bago Corporation Information
Table 96. Biogenesis-Bago Description and Business Overview
Table 97. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 98. Biogenesis-Bago Brucellosis Vaccines Product
Table 99. Biogenesis-Bago Recent Development
Table 100. Vetal Company Corporation Information
Table 101. Vetal Company Description and Business Overview
Table 102. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 103. Vetal Company Brucellosis Vaccines Product
Table 104. Vetal Company Recent Development
Table 105. CZ Veterinaria Corporation Information
Table 106. CZ Veterinaria Description and Business Overview
Table 107. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 108. CZ Veterinaria Brucellosis Vaccines Product
Table 109. CZ Veterinaria Recent Development
Table 110. SYVA Laboratorios Corporation Information
Table 111. SYVA Laboratorios Description and Business Overview
Table 112. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 113. SYVA Laboratorios Brucellosis Vaccines Product
Table 114. SYVA Laboratorios Recent Development
Table 115. Indian Immunologicals Corporation Information
Table 116. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 117. Indian Immunologicals Description and Business Overview
Table 118. Indian Immunologicals Brucellosis Vaccines Product
Table 119. Indian Immunologicals Recent Development
Table 120. Qilu Corporation Information
Table 121. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 122. Qilu Description and Business Overview
Table 123. Qilu Brucellosis Vaccines Product
Table 124. Qilu Recent Development
Table 125. Tecnovax Corporation Information
Table 126. Tecnovax Description and Business Overview
Table 127. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 128. Tecnovax Brucellosis Vaccines Product
Table 129. Tecnovax Recent Development
Table 130. Hester Biosciences Corporation Information
Table 131. Hester Biosciences Description and Business Overview
Table 132. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 133. Hester Biosciences Brucellosis Vaccines Product
Table 134. Hester Biosciences Recent Development
Table 135. Zoetis Corporation Information
Table 136. Zoetis Description and Business Overview
Table 137. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 138. Zoetis Brucellosis Vaccines Product
Table 139. Zoetis Recent Development
Table 140. Onderstepoort Biological Corporation Information
Table 141. Onderstepoort Biological Description and Business Overview
Table 142. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 143. Onderstepoort Biological Brucellosis Vaccines Product
Table 144. Onderstepoort Biological Recent Development
Table 145. Instituto Rosenbusch Corporation Information
Table 146. Instituto Rosenbusch Description and Business Overview
Table 147. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 148. Instituto Rosenbusch Brucellosis Vaccines Product
Table 149. Instituto Rosenbusch Recent Development
Table 150. Ceva Sante Animale Corporation Information
Table 151. Ceva Sante Animale Description and Business Overview
Table 152. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 153. Ceva Sante Animale Brucellosis Vaccines Product
Table 154. Ceva Sante Animale Recent Development
Table 155. Calier & Biologicos Laverlam Corporation Information
Table 156. Calier & Biologicos Laverlam Description and Business Overview
Table 157. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 158. Calier & Biologicos Laverlam Brucellosis Vaccines Product
Table 159. Calier & Biologicos Laverlam Recent Development
Table . Biovet Corporation Information
Table . Biovet Description and Business Overview
Table . Biovet Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table . Biovet Brucellosis Vaccines Product
Table . Biovet Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Brucellosis Vaccines Distributors List
Table 168. Brucellosis Vaccines Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucellosis Vaccines Product Picture
Figure 2. Global Brucellosis Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Brucellosis Vaccines Market Share by Application in 2020 & 2026
Figure 6. Cattle Examples
Figure 7. Sheep Examples
Figure 8. Other Examples
Figure 9. Global Brucellosis Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 10. Global Brucellosis Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Brucellosis Vaccines Price Trends Growth Rate (2015-2026) (USD/K Doses)
Figure 12. Global Brucellosis Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Brucellosis Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Brucellosis Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Brucellosis Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 16. Europe Brucellosis Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Brucellosis Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Brucellosis Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Brucellosis Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Brucellosis Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Brucellosis Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Brucellosis Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Brucellosis Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Brucellosis Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Brucellosis Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Brucellosis Vaccines Players Market Share by Revenue in Brucellosis Vaccines 2015 & 2019
Figure 27. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Brucellosis Vaccines Revenue Share by Type (2015-2020)
Figure 29. Global Brucellosis Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Brucellosis Vaccines Revenue Share by Application (2015-2020)
Figure 31. Global Brucellosis Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Brucellosis Vaccines Sales Market Share by Type in 2019
Figure 33. United States Brucellosis Vaccines Sales Market Share by Type in 2019
Figure 34. Europe Brucellosis Vaccines Sales Market Share by Company in 2019
Figure 35. Europe Brucellosis Vaccines Sales Market Share by Type in 2019
Figure 36. Europe Brucellosis Vaccines Sales Market Share by Application in 2019
Figure 37. China Brucellosis Vaccines Sales Market Share by Company in 2019
Figure 38. China Brucellosis Vaccines Sales Market Share by Type in 2019
Figure 39. China Brucellosis Vaccines Sales Market Share by Application in 2019
Figure 40. Japan Brucellosis Vaccines Sales Market Share by Company in 2019
Figure 41. Japan Brucellosis Vaccines Sales Market Share by Type in 2019
Figure 42. Japan Brucellosis Vaccines Sales Market Share by Application in 2019
Figure 43. Southeast Asia Brucellosis Vaccines Sales Market Share by Company in 2019
Figure 44. Southeast Asia Brucellosis Vaccines Sales Market Share by Type in 2019
Figure 45. Southeast Asia Brucellosis Vaccines Sales Market Share by Application in 2019
Figure 46. India Brucellosis Vaccines Sales Market Share by Company in 2019
Figure 47. India Brucellosis Vaccines Sales Market Share by Type in 2019
Figure 48. India Brucellosis Vaccines Sales Market Share by Application in 2019
Figure 49. Jinyu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Colorado Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Biogenesis-Bago Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Vetal Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. CZ Veterinaria Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. SYVA Laboratorios Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Qilu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Tecnovax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hester Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Onderstepoort Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Instituto Rosenbusch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Calier & Biologicos Laverlam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Biovet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Brucellosis Vaccines
Figure 68. Manufacturing Process Analysis of Brucellosis Vaccines
Figure 69. Brucellosis Vaccines Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- mRNAワクチンおよび治療薬の世界市場レポート2020 mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…
- マラリアワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Malaria Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.4% in the forecast period of 2020 to 2025 and will expected to reach USD 23 million by 2025, from USD 14 million in 2019. The Malaria Vaccines market re…
- 経口ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Oral Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data…